Resistance to Anti-VEGF Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|1|51-64

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.1, 2004-01, pp. : 51-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents

By Mir Olivier  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 716-718

Springer Publishing Company

Access to resources Recommend Favorite

Anti-VEGF Treatment of Corneal Neovascularization

By Keating Anne M.   Jacobs Deborah S.  

The Ocular Surface, Vol. 9, Iss. 4, 2011-10 ,pp. : 227-238

Ethis Communications

Access to resources Recommend Favorite

Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 497-508

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Therapy for Retinal Vein Occlusions

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 328-336

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Molecules for the Management of Diabetic Macular Edema

By  

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4731-4737

Bentham Science Publishers

Access to resources Recommend Favorite